Yuan-Sung Kuo

Title: Innovations of Yuan-Sung Kuo in Thromboembolism Treatment.

Introduction

Yuan-Sung Kuo is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of thromboembolism-related diseases. His innovative work focuses on synthetic peptides that enhance therapeutic efficacy and safety.

Latest Patents

Yuan-Sung Kuo holds a patent for "Synthetic peptides, pharmaceutical compositions comprising the same, and uses thereof in treating thromboembolism-related diseases." This patent discloses a biomolecule that includes a synthetic peptide designed to target thrombus. The synthetic peptide, characterized by specific amino acid sequences, demonstrates a binding affinity and specificity to thrombus. This innovation allows for the targeted delivery of therapeutic agents, such as anticoagulants or thrombolytics, thereby improving treatment outcomes.

Career Highlights

Kuo is affiliated with Academia Sinica, where he conducts research and development in the pharmaceutical sciences. His work has garnered attention for its potential to revolutionize treatment protocols for thromboembolism, a condition that poses significant health risks.

Collaborations

Yuan-Sung Kuo collaborates with Han-Chung Wu, contributing to advancements in their shared field of research. Their partnership exemplifies the collaborative spirit of scientific inquiry and innovation.

Conclusion

Yuan-Sung Kuo's contributions to the field of thromboembolism treatment through his innovative patent highlight the importance of targeted therapies in modern medicine. His work continues to pave the way for advancements in pharmaceutical compositions and therapeutic strategies.